Published in
Elsevier, Annals of Oncology, (34), p. S517, 2023
DOI: 10.1016/j.annonc.2023.09.1934
Links
Tools
755P Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)
Journal article published in 2023 by
D. Berton-Rigaud,
P. Pautier,
D. Lorusso,
C. Gennigens,
L. Gladieff,
A. Kryzhanivska,
J. Bowman,
C. Tian,
M. Cornfeld,
T. Van Gorp 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 